Combined therapy with osimertinib and afatinib in a lung adenocarcinoma patient with EGFR T790M mutation and multiple HER2 alterations after resistance to icotinib: A case report

Những quyển sách tương tự

• Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR
  Bằng: Sakai, Hitomi, et al.
  Được phát hành: (2017)
• Case report: primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation
  Bằng: Zheng, Lin-Peng, et al.
  Được phát hành: (2018)
• Combination therapy of apatinib with icotinib for primary acquired icotinib resistance in patients with advanced pulmonary adenocarcinoma with EGFR mutation
  Bằng: Xia, Pinghui, et al.
  Được phát hành: (2018)
• EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
  Bằng: Kim, Minhye, et al.
  Được phát hành: (2021)
• Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib
  Bằng: Hochmair, Maximilian J., et al.
  Được phát hành: (2018)